Search results
BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceedi
Guru Focus· 20 minutes agoBioCryst Pharmaceuticals Inc (BCRX, Financial) released its 8-K filing on May 6, 2024, announcing robust financial results for the first quarter ended March 31, 2024. The ...
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 2 hours agoVerrica Pharmaceuticals (VRCA) was a big mover last session on higher-than-average trading volume....
Cipla and Glenmark initiate recall of certain products in the US
Pharmaceutical Technology via Yahoo Finance· 2 hours agoCipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to...
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
KGTV San Diego· 7 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 2 hours agoYou can see all of today’s research reports here >>> Shares of AstraZeneca have gained +4.1% over...
Pharma and Medical Startups on the Hook to Attract Strong Counsel
Bloomberg Law· 4 hours agoStartup and midsize pharmaceutical and medical device companies face a range of challenges that need the help of a strong legal team from hiring to conducting clinical trials ...
AI Transforms Drug Discovery With Faster, Safer Cancer Treatments
SciTechDaily· 3 hours agoSan Diego have developed a machine learning algorithm to simulate the time-consuming chemistry...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Arkansas Democrat...
Arkansas Democrat-Gazette· 24 hours agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
Zacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
ETF DAILY NEWS· 9 hours agoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Zacks Research decreased their Q1 2025 earnings per share estimates for Deciphera Pharmaceuticals< ...
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Benzinga via Yahoo Finance· 7 days agoOn Monday, Japanese pharma company ONO Pharmaceutical agreed to acquire Deciphera Pharmaceuticals...